TAMER TADROS: Open Payments
NPI 1184254666 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 21 payments from 14 companies in 2025. Trend: 2023 $225 · 2024 $641 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $64 |
| Amgen Inc. | 3 | $50 |
| Abbott Laboratories | 2 | $49 |
| Novo Nordisk Inc | 2 | $44 |
| Almatica Pharma LLC | 2 | $36 |
| Medtronic, Inc. | 2 | $33 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| Tandem Diabetes Care, Inc. | 1 | $23 |
| Soleno Therapeutics, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: Dexcom G6 Transmitter, FREESTYLE LIBRE 3, TERIPARATIDE, MINIMED 780G, EVENITY, Wegovy, TZIELD, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across FL — which companies pay providers there.
